Authors: Nunes-Moreno, M., Furniss, A., Cortez, S., Davis, S, M., Dowshen, N., Kazak, A, E., Nahata, L., Pyle, L., Reirden, D, H., Schwartz, B., Sequeira, M, G., Nokoff, N, J.
Date of publication: 2024
Journal: LGBT Health
Summary: This study analysed paediatric medical data over a ten-year period to find out the most common reasons for admission to the emergency department or inpatient ward amongst transgender and gender-diverse (TGD) youth. The authors defined TGD patients as those with a diagnosis of gender dysphoria and they then compared this data with patients who did not have a diagnosis of gender dysphoria. In addition to this, the authors analysed whether access to gender-affirming hormone therapy (GAHT) or Gonadotropin-releasing hormone agonist (GnRHa) decreased suicidality amongst TGD youth.
The authors found that TGD youth had a higher risk of being admitted to the emergency department or inpatient unit for suicidality and other mental health related diagnoses than those who did not have a diagnosis of gender dysphoria. The authors also found that for TGD youth, a prescription for GAHT reduced the risk of an ED or inpatient admission for suicidality compared to TGD youth who did not have a prescription. They did not find a significant reduction in admissions amongst TGD youth with a GnRHa prescription.
You can read a summary only of the study here
1
2
3
4
5
Skip this question >